Twenty-six of 30 metastatic breast cancers in lymph nodes were positive for TRMT11-GRIK2, including seven metastatic cancers whose matched primary breast cancers were negative for the fusion. This evidence concerns the gene TRMT11 and metastatic malignant neoplasm.